Advertisement

Maternal Use of NSAID Drugs and Infant Congenital Malformations

  • Bengt Källén
Chapter

Abstract

The literature on teratogenic effects of NSAID is large but inconsistent. Well-performed studies have indicated a moderately increased risk for cardiac defects after at least some NSAIDs and notably naproxen. There also seems to be an association between maternal use of the propionic acid derivatives ibuprofen and naproxen and infant cleft lip/palate, so far not seen for other NSAIDs. Avoidance of these drugs and notably naproxen in early pregnancy can be recommended but if exposure has occurred, the individual risk is low. Further data are needed on the use of coxibs in early pregnancy.

References

  1. Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O’Keeffe M, Thomas SH. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. Eur J Pharmacol. 2004;60:635–41.Google Scholar
  2. Cassina M, De Santis M, Cesari E, van Eijkeren M, Berkovitch M, Eleftheriou G, Raffagnato E, Di Gianantonio E, Clementi M. First trimester diclofenac exposure and pregnancy outcome. Reprod Toxicol. 2010;30:401–4.CrossRefGoogle Scholar
  3. Cleves MA, Savell VH Jr, Raj S, Zhao W, Correa A, Werler MM, Hobbs CA, National Birth Defects Prevention Study. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res A Clin Mol Teratol. 2004;70:107–13.CrossRefGoogle Scholar
  4. Dathe K, Padberg S, Hulzsch S, Köhler L-M, Meixner K, Fietz A-K, Tissen-Diabate T, Meister R, Schaefer C. Exposure to cox-2 inhibitors (coxibs) during the 1st trimester and pregnancy outcome: a prospective observational cohort study. Eur J Clin Pharmacol. 2018;74:489–95.CrossRefGoogle Scholar
  5. Daniel S, Matok J, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A. Major malformations following exposure to nonsteroidal antinflammatory drugs during the first trimester of pregnancy. J Rheumatol. 2012;39:2163–9.CrossRefGoogle Scholar
  6. Ericson A, Källén B. Non-steroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol. 2001;15:371–5.CrossRefGoogle Scholar
  7. Hernandez R, Werler M, Romitti P, Sun L, Anderka M, The National Birth Defects Prevention Study. Nonsteroidal anti-inflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol. 2012;206:228.e1–8.CrossRefGoogle Scholar
  8. Interrante JD, Alles EC, Lind JN, Anderka M, Feldkamp ML, Werler MM, Taylor LG, Trinidad J, Gilboa SM, Broussard CS, National Birth Defects Prevention Study. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011. Ann Epidemiol. 2017;27:645–53.CrossRefGoogle Scholar
  9. Källén B, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003;17:255–61.CrossRefGoogle Scholar
  10. Nezvalová-Henriksen K, Spigset O, Nordeng H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG. 2013;120:948–59.CrossRefGoogle Scholar
  11. Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322:266–70.CrossRefGoogle Scholar
  12. Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol. 2006;77:268–79.CrossRefGoogle Scholar
  13. Schoenfeld A, Bar Y, Merlob P, Ovaredia Y. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol. 1992;28:141–7.CrossRefGoogle Scholar
  14. Van Gelder MMHJ, Roeleveld N, Nordeng H. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study. PLoS One. 2011;6:e22174.  https://doi.org/10.1371/journal.pone.002174.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Bengt Källén
    • 1
  1. 1.Tornblad Institute for Comparative EmbryologyLund UniversityLundSweden

Personalised recommendations